In this Q&A from Dr. Anna Blakney’s lab at the Michael Smith Laboratories and School…
sciencecitySeptember 7, 2023
The ALS Society of BC and the University of British Columbia (UBC) are pleased to…
sciencecitySeptember 6, 2023
Our research focuses on herpes simplex virus 2 (HSV-2), a sexually transmitted virus that causes…
pthomsonSeptember 4, 2023
The genome of Caenorhabditis elegans encodes 284 nuclear hormone receptor, which perform diverse functions in…
pthomsonSeptember 4, 2023
Diabetes is a disease in which the body either can’t produce insulin (type 1), or…
pthomsonSeptember 1, 2023
Dr. Franck Duong (pictured) at UBC received an NSERC Discovery Grant for a project on…
pthomsonSeptember 1, 2023
Several major childhood allergies may all stem from the community of bacteria living in our…
pthomsonAugust 31, 2023
One aspect of human existence we know to be universal is that we each have…
eabramovichDecember 9, 2020
Having already raised $105 million in a Series B in May, Canadian R&D engine AbCellera is gearing up for…
eabramovichDecember 8, 2020
With great pleasure we announce the appointment of our own Dr. Jim Johnson as the…
eabramovichDecember 7, 2020
“Biomimicry,” the ability to replicate the functions of biological molecules with synthetic analogs, is one…
eabramovichDecember 7, 2020
Researchers have revealed another benefit of using whole genome and transcriptome sequencing to inform cancer patient care: the detection…
eabramovichDecember 4, 2020
A national consortium including Genome BC will expand development of a software platform for genomics…
eabramovichDecember 4, 2020
The development of immune checkpoint inhibitors (ICI), a type of cancer therapy that helps the immune system…
eabramovichDecember 1, 2020
Symvivo Corporation, a clinical-stage biotechnology company advancing a proprietary bacTRL™ gene delivery platform, announced today…
eabramovichNovember 27, 2020
